What does a white blood cell count of 18.2 ×10⁹/L with absolute neutrophils 15.3 ×10⁹/L, absolute metamyelocytes 364 (2 % of leukocytes), platelets 462 ×10⁹/L, and absolute eosinophils 0 indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Leukemoid Reaction with Left Shift - Likely Bacterial Infection or Myeloproliferative Process

This laboratory pattern—WBC 18.2 ×10⁹/L with absolute neutrophils 15.3 ×10⁹/L, 2% metamyelocytes (364 cells/µL), thrombocytosis (462 ×10⁹/L), and absent eosinophils—strongly suggests either an acute bacterial infection with leukemoid reaction or an early myeloproliferative disorder, most notably chronic myeloid leukemia (CML).

Immediate Diagnostic Approach

Key Distinguishing Features to Assess

The presence of metamyelocytes (immature granulocytes) at 2% represents a significant left shift that warrants immediate evaluation. According to IDSA guidelines, a left shift defined as ≥6% bands/metamyelocytes or absolute band count ≥1,500 cells/mm³ has a likelihood ratio of 14.5 for bacterial infection 1. Your patient's absolute metamyelocyte count of 364 cells/µL, while notable, falls below this threshold but still indicates bone marrow activation.

Critical clinical context needed:

  • Fever, localizing symptoms, or signs of infection (pneumonia, urinary symptoms, abdominal pain)
  • Splenomegaly (palpable spleen strongly suggests CML)
  • Constitutional symptoms (weight loss, night sweats, fatigue suggest malignancy)
  • Recent trauma or surgery (post-splenectomy can cause similar findings) 2
  • Medication history (corticosteroids, lithium, beta-agonists cause leukocytosis) 3, 4

The Eosinophil Paradox

Absolute eosinophils of 0 is highly significant. Eosinopenia (eosinophils <40 cells/µL) has 94% specificity for bacterial infection, particularly urinary and biliary tract infections 5. This finding strongly favors infection over CML, where eosinophilia and basophilia are typically present 6, 7.

Algorithmic Decision Tree

If Clinical Signs of Infection Present:

  1. Immediate sepsis workup: Blood cultures, urinalysis/urine culture, chest X-ray as indicated
  2. Start empiric antibiotics if sepsis suspected—do not wait for culture results
  3. Repeat CBC in 24-48 hours: Bacterial infection should show improvement with treatment; persistent or worsening leukocytosis suggests alternative diagnosis 8

If No Clear Infectious Source:

Proceed with hematologic evaluation for CML:

  1. Peripheral blood smear review (manual differential already done—look for basophilia, blast percentage)
  2. BCR-ABL1 testing (RT-PCR or FISH for Philadelphia chromosome) 6, 7
  3. Bone marrow biopsy if BCR-ABL1 positive or high clinical suspicion
  4. Assess for splenomegaly (physical exam, imaging if needed)

Chronic Myeloid Leukemia Considerations

While your WBC of 18.2 ×10⁹/L is elevated, CML typically presents with much higher counts (median 240 ×10⁹/L in pediatric series, often >100 ×10⁹/L in adults) 9, 10. However, early-phase CML can present with more modest elevations 6, 2.

CML diagnostic criteria require:

  • Philadelphia chromosome (BCR-ABL1 fusion) confirmation 6, 7
  • Characteristic left shift with all stages of granulocyte maturation
  • Basophilia and eosinophilia (your patient has neither, arguing against CML)
  • Thrombocytosis (present in your patient at 462 ×10⁹/L)
  • Splenomegaly (not mentioned in your case)

If CML is diagnosed:

  • Immediate cytoreduction with hydroxyurea 25-50 mg/kg/day if WBC >100 ×10⁹/L or symptomatic 9, 10
  • Tyrosine kinase inhibitor (imatinib 400 mg daily) as definitive therapy 6, 7
  • Risk stratification using ELTS score 9

Most Likely Diagnosis

Given the constellation of findings—moderate leukocytosis, left shift with metamyelocytes, thrombocytosis, and particularly the eosinopenia—this pattern most strongly suggests acute bacterial infection 1, 5. The absence of eosinophils and basophils argues against CML at this stage.

Common Pitfalls to Avoid

  • Do not dismiss leukocytosis as "stress response" without excluding infection or malignancy 3, 4
  • Do not assume CML based solely on left shift and thrombocytosis—BCR-ABL1 testing is mandatory for diagnosis 6
  • Do not delay antibiotics if infection is suspected while awaiting hematologic workup 1
  • Repeat CBC is essential: Persistent abnormalities after treating presumed infection mandate hematology referral 8, 3

Immediate Next Steps

  1. Obtain detailed history focusing on infectious symptoms, constitutional symptoms, medications, and trauma
  2. Physical examination for splenomegaly, lymphadenopathy, focal infection
  3. If infection suspected: Cultures, imaging, empiric antibiotics
  4. If no infection identified: BCR-ABL1 testing and hematology consultation
  5. Repeat CBC in 48-72 hours regardless of initial impression

References

Research

Evaluation of Patients with Leukocytosis.

American family physician, 2015

Research

Leukocytosis: basics of clinical assessment.

American family physician, 2000

Research

White blood cell count and eosinopenia as valuable tools for the diagnosis of bacterial infections in the ED.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019

Research

Neutrophil left shift and white blood cell count as markers of bacterial infection.

Clinica chimica acta; international journal of clinical chemistry, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.